LB Pharmaceuticals Stock (NASDAQ:LBRX)
Previous Close
$24.35
52W Range
$13.36 - $24.95
50D Avg
$21.43
200D Avg
$18.48
Market Cap
$590.48M
Avg Vol (3M)
$296.97K
Beta
-8.80
Div Yield
-
LBRX Company Profile
Clinical‑stage biopharmaceutical company developing novel therapies for neuropsychiatric diseases (e.g. schizophrenia, bipolar depression). Lead candidate is LB‑102, a methylated derivative of amisulpride.